These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 27028351

  • 1. Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Krhili S, Muratet JP, Roche S, Pointreau Y, Yossi S, Septans AL, Denis F.
    Am J Clin Oncol; 2017 Jun; 40(3):250-255. PubMed ID: 27028351
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Hong JH, Jung US, Min KJ, Lee JK, Kim S, Eo JS.
    Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362
    [Abstract] [Full Text] [Related]

  • 4. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
    Leseur J, Roman-Jimenez G, Devillers A, Ospina-Arango JD, Williaume D, Castelli J, Terve P, Lavoue V, Garin E, Lejeune F, Acosta O, De Crevoisier R.
    Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L, Mucientes-Rasilla J, San-Frutos Llorente LM, Royuela A, Garcia-Espantaleón Navas M, Herrero Gámiz S, Pérez-Medina T.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019 Sep; 38(1):17-21. PubMed ID: 30366731
    [Abstract] [Full Text] [Related]

  • 6. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG, Moustafa HM, Khalil HF, Liao CT, Yen TC.
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
    Guler OC, Torun N, Yildirim BA, Onal C.
    Br J Radiol; 2018 Apr; 91(1084):20170552. PubMed ID: 29293366
    [Abstract] [Full Text] [Related]

  • 8. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
    Voglimacci M, Gabiache E, Lusque A, Ferron G, Ducassou A, Querleu D, Motton S, Chantalat E, Courbon F, Martinez A.
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1551-1559. PubMed ID: 30729273
    [Abstract] [Full Text] [Related]

  • 9. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
    Sun Y, Lu P, Yu L.
    Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
    [Abstract] [Full Text] [Related]

  • 10. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.
    Vojtíšek R, Baxa J, Kovářová P, Almortaza A, Hošek P, Sukovská E, Tupý R, Ferda J, Fínek J.
    Strahlenther Onkol; 2021 Jun; 197(6):494-504. PubMed ID: 33492444
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO, Jeong SY, Park SH, Lee YH, Lee SW, Hong DG, Kim JC, Lee YS, Cho YL.
    PLoS One; 2015 Jun; 10(9):e0137743. PubMed ID: 26368542
    [Abstract] [Full Text] [Related]

  • 12. (18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
    Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [Abstract] [Full Text] [Related]

  • 13. The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.
    Rufini V, Collarino A, Calcagni ML, Meduri GM, Fuoco V, Pasciuto T, Testa AC, Ferrandina G, Gambacorta MA, Campitelli M, Gui B, Zannoni G, Manfredi R, Scambia G, Giordano A.
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
    Son SH, Jeong SY, Chong GO, Lee YH, Park SH, Lee CH, Hong CM, Jeong JH, Lee SW, Ahn BC, Lee J.
    Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
    [Abstract] [Full Text] [Related]

  • 15. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
    Ueno Y, Lisbona R, Tamada T, Alaref A, Sugimura K, Reinhold C.
    Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
    [Abstract] [Full Text] [Related]

  • 16. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR, Hricak H, Sala E.
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH, Kang SY, Ha S, Kim JW, Park NH, Song YS, Cheon GJ.
    J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
    [Abstract] [Full Text] [Related]

  • 18. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.